Femme et Homme
- | Pays :
- Malaysia
- | Organes : -
- | Spécialités : -
Extrait
This is a single-center, cross-over comparison parallel group randomized trial designed to evaluate the efficacy and safety of Ganfort compared to Duotrav for a treatment period of 8 weeks each.
Critère d'inclusion
- Ocular hypertension ,Primary open-angle glaucoma